About The Study:
Social anxiety disorder is a mental health condition that can be very debilitating and persistent. People with this disorder tend to feel extreme fear when going out in public and interacting with others. This fear tends to control people’s lives and affects how they go to school, work, or do daily activities. Symptoms can include feelings of humiliation and self-consciousness, an upset stomach, sweating, rapid heart rate, and finding it difficult to speak or make eye contact. Social anxiety is one of the most common mental health disorders and there are around 5.3 million people who suffer from it in the United States. Treatment for this disorder is usually antidepressants, but not everyone wants to take them because of the way it makes them feel.
Rochester Clinical Research is participating in a study evaluating the safety and efficacy of taking 2 doses of CBD when treating social anxiety disorder in people who suffer from it. We are seeking participants who are between the ages of 18-75 years old. The study will last approximately 16 weeks and include 9 visits to our office.
Study-related care is available to participants at no cost and health insurance is not required nor needed. Compensation for time and travel is available for up to $900 to those who qualify.
Qualifications
- Between the ages of 18-75 years old
- Can agree to abstain from the use of recreational and medicinal cannabis, CBD products, THC, or any other cannabinoids, for the duration of the study.
- *Please note, that other conditions may apply